Summary
Procter & Gamble's (PG) fiscal first quarter ended September 30, 2009, saw a 6% decline in net sales to $19.8 billion, primarily due to unfavorable foreign exchange rates. However, organic sales grew by 2%, indicating underlying brand strength. Net earnings from continuing operations decreased by 3% to $3.03 billion, impacted by lower net sales and a decrease in gains from minor brand divestitures, though this was partially offset by an improved operating margin and lower interest expenses. Despite the top-line challenges, the company demonstrated strong operational execution. Diluted net earnings per share (EPS) rose by 3% to $1.06, outperforming net earnings growth due to share repurchase activity. Operating cash flow saw a significant 32% increase to $4.6 billion, with free cash flow productivity at a robust 121%. The company also announced the agreement to sell its global pharmaceuticals business for $3.1 billion, which is expected to be completed by year-end, and its results are now presented as discontinued operations.
Financial Highlights
50 data points| Revenue | $19.81B |
| Cost of Revenue | $9.40B |
| Gross Profit | $10.41B |
| SG&A Expenses | $5.96B |
| Operating Income | $4.45B |
| Interest Expense | $287.00M |
| Net Income | $3.31B |
| EPS (Basic) | $1.11 |
| EPS (Diluted) | $1.06 |
| Shares Outstanding (Diluted) | 3.11B |
Key Highlights
- 1Net sales decreased by 6% to $19.8 billion, negatively impacted by foreign exchange, but organic sales grew 2%.
- 2Diluted net earnings per share (EPS) increased by 3% to $1.06, exceeding net earnings growth due to share repurchases.
- 3Operating cash flow significantly increased by 32% to $4.6 billion, showcasing strong cash generation capabilities.
- 4Free cash flow productivity was strong at 121%, indicating efficient conversion of earnings into cash.
- 5The company is divesting its global pharmaceuticals business for $3.1 billion, with results now categorized as discontinued operations.
- 6Gross margin improved by 290 basis points to 52.6%, driven by pricing actions, lower commodity costs, and cost savings.
- 7The company reported a 3% decline in net earnings from continuing operations to $3.03 billion, but a 1% decrease in total net earnings to $3.31 billion.